Condom Use During Chemotherapy

Primary Recommendation

• The American Society of Clinical Oncology (ASCO) recommends that patients receiving active chemotherapy either abstain from sexual activity or use barrier protection (condoms or dental dams) for 48–72 hours after each chemotherapy administration to protect partners from exposure to chemotherapy metabolites. Evidence is limited; the guideline is based on expert consensus rather than high‑quality trials. 1

Evidence Strength and Consensus

• ASCO acknowledges that the 48–72 hour recommendation lacks strong evidence‑based support and is derived from a low‑strength consensus guideline, representing the most conservative approach given the paucity of data on partner exposure risks. 2

Barrier‑Protection Requirements

• Condoms or dental dams should be used whenever a partner’s saliva, vaginal secretions, or semen could enter the mouth during sexual activity, and this applies throughout the chemotherapy course and during the 48–72 hour post‑dose window. 2

Hematologic Considerations

• In patients with thrombocytopenia (low platelet counts), penetrative sexual activity should be avoided entirely because of an increased risk of bleeding and bruising. 2
• In patients with neutropenia (low neutrophil counts), anal or vaginal penetration with any body parts or objects should be avoided due to a heightened risk of infection from mucosal trauma. 2

Contraception

• Effective contraception remains essential for patients of reproductive potential, as chemotherapy can cause severe fetal harm and may diminish the efficacy of hormonal methods; barrier methods provide both partner protection and contraception. 2

Duration of Precautions

• The 48–72 hour barrier‑protection window must be applied after each individual chemotherapy treatment session, meaning that patients on continuous or frequent cycles need ongoing barrier use throughout active treatment. 1
• No specific guidance exists for how long condom use should continue after the entire chemotherapy regimen is completed; the concern is limited to the period of active drug excretion during and shortly after treatment. 1

Clinical Documentation

• Discussions regarding sexual activity, partner protection, and contraception should be documented in the medical record and initiated early—ideally before chemotherapy begins. 3